Similarly, CCR6, a chemokine receptor selectively expressed in Th17 cells and Tregs, can mediate the migration of circulating Tregs to the TME through the CCL20-CCR6 axis, leading to tumour progression and poor prognosis (117). Here, CCL20 is linked to neoplasm.